FMP
NASDAQ
0.86 USD
0.06 (6.98%)
Mr. Vincent J. Angotti
Healthcare
Drug Manufacturers - Specialty & Generic
https://www.acelrx.com
NASDAQ
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. Its lead product candidate is DSUVIA and DZUVEO, a 30 mcg sufentanil sublingual tablet for the treatment of moderate-to-severe acute pain. The company develops ZALVISO, a pre-programmed and patient-controlled analgesia system that allows hospital patients with moderate-to-severe acute pain to self-dose with sufentanil sublingual tablets to manage their pain; ARX-02, which is in Phase 2 clinical trial for the treatment of cancer breakthrough pain in opioid-tolerant patients; and 4ARX-03 for mild sedation and pain relief during painful...
0001427925
US00444T2096
00444T100
25821 Industrial Boulevard
650 216 3500
US
19
Feb 11, 2011
0001427925
NASDAQ
Drug Manufacturers -...
Healthcare
00444T100
US00444T2096
US
0.86
0.52
138.82k
14.58M
-
0.425-2.3
2.37
-
-
-
-
-0.31
-
https://www.acelrx.com
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
It looks like there's no news available.